Thanks - I like the company - the've just had a lot of heat regarding their Zohydro product- some fair some unfair. Combine that with the increase in shorting and the ten cent gap looked huge. Glad they are focussing on ADT now. Smart move.
Fear Uncertainty and Doubt FUD It Ain't Going To Work Here Anymore. Notice the lack of question mark.